Ocular: Ocular Therapeutix to Participate in Upcoming Investor and Scientific Conferences

BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific conferences in the first half of May 2025.Upcoming Investor ConferencesCitizens JMP Life Sciences Conference 2025:Fireside Chat Date: Wednesday, May 7, 2025Fireside Chat Time: 9:00 AM ETPresenter: Pravin U. Dugel, MD, Executive Chairman, President and CEOLocation: New York, NYBank of America 2025 Global Healthcare Conference:Fireside Chat Date: Tuesday, May 13, 2025Fireside Chat Time: 9:20 AM PTPresenter: Pravin U. Dugel, MD, Executive Chairman, President and CEOLocation: Las Vegas, NVA live webcast of the fireside chats can be accessed by visiting the Ocular Therapeutix website on the Events and Presentations section of the Investor Relations page.Upcoming Scientific ConferencesEyecelerator @ Park City 2025: Park City, UtahPanel Title: Retina in OfficeSession 5: I Shall be Released: Novel Drug Delivery Approaches for Glaucoma and RetinaSession Date/Time: Friday, May 2, 2025, 12:30 - 1:30 PM MTPanelist: Nadia K. Waheed, MD, MPH, Chief Medical OfficerPanel Title: Retina in ORSession 5: I Shall be Released: Novel Drug Delivery Approaches for Glaucoma and RetinaSession Date/Time: Friday, May 2, 2025, 12:30 - 1:30 PM MTModerator: Namrata Saroj, OD, Chief Business OfficerCompany Presentation: Ocular TherapeutixSession: Retina - TKI and Drug Delivery ShowcasePresentation Date/Time: Friday, May 2, 2025, 1:38 ...Full story available on Benzinga.com